Reata Pharmaceuticals, Inc. (RETA) News Headlines

▮ More

Date

Headline

11/29/2021 2:53:36 AM Biotech Stocks Facing FDA Decision In December 2021

8/10/2021 11:38:00 AM Reata Pharma Down 17% On Q2 Net Loss

5/19/2021 7:43:39 AM Reata Says FDA Requests Pre-NDA Meeting For Omaveloxolone To Treat Friedreich's Ataxia - Quick Facts

3/1/2021 6:41:50 AM Reata Pharma FY GAAP Loss Per Share $7.35; Non-GAAP Loss Per Share $4.70

12/2/2020 10:17:59 AM Stock Alert: Reata Pharmaceuticals Falls 10%

8/11/2020 1:57:59 AM CPRX Plunges As MuSK-MG Trial Flops, MESO Awaits FDA Panel Review, EQ Soars After-hrs

8/10/2020 10:35:01 AM Stock Alert: Reata Pharmaceuticals Tanks 30% As Rare Genetic Disease Drug In Limbo

7/7/2020 6:50:03 AM Reata Promotes Colin Meyer To Newly Created Position Of Chief Research And Development Officer And EVP

6/24/2020 10:16:12 AM Reata Reports Receipt Of $350 Mln Related To Closing Of Investment From Blackstone Life Sciences

6/11/2020 10:52:23 AM Stock Alert: Reata Pharma Climbs 27% Following Investment By Blackstone Life Sciences

3/31/2020 10:49:06 AM Stock Alert: Reata Pharma Down 10%, Stops Drug Trials

3/31/2020 12:03:52 AM AMRN's Vascepa Woes, AKRO Awaits Big Day, JNJ's COVID-19 Vaccine Study In Sep

3/3/2020 9:23:54 AM Stock Alert: CNS Pharma Up On Brain Cancer Trial Update

Older Articles